首页|高钾血症对维持性血液透析患者3月内全因死亡及心血管疾病死亡的影响

高钾血症对维持性血液透析患者3月内全因死亡及心血管疾病死亡的影响

扫码查看
目的:多中心回顾性队列研究血钾水平对维持性血液透析(MHD)患者 3 月内全因死亡及心血管疾病(CVD)死亡的影响.方法:选择 2010-01-01~2019-12-31 浙江省透析质控中心登记系统中新入的成人MHD患者.收集一般资料及实验室指标.根据MHD随访终点前 3 月内透析前血钾的最高值,将患者分为 8 组,应用Kaplan-Meier法比较各组患者全因死亡和CVD死亡之间的生存差异,采用多因素COX回归分析血钾水平与全因死亡及CVD死亡的相关性.结果:共纳入患者21 861 例,其中男性13 465 例(61.6%),平均年龄(61.1±15.4)岁,10 132 例(46.3%)患者合并CVD.中位随访时间 34(19,56)月,发生全因死亡 4 635 例(21.2%),其中CVD 1 319例(6.0%).血钾水平<3.5 mmol/L患者 759 例(3.5%),血钾水平≥5.0 mmol/L患者 9 782 例(44.7%),血钾水平≥5.5 mmol/L患者5 420 例(24.7%).Kaplan-Meier生存曲线显示,不同血钾水平组全因死亡风险(Log-rank检验,χ2=248.0,P<0.001)、CVD死亡风险(Log-rank检验,χ2=96.6,P<0.001)差异均有统计学意义.多因素COX回归分析显示,血钾水平≥5.5 mmol/L是MHD患者 3 月内全因死亡(5.5≤血钾<6.0 mmol/L,HR=1.34 95%CI 1.08~1.67,P=0.008;6.0≤血钾<6.5 mmol/L,HR=1.53,95%CI 1.18~2.00,P=0.001;血钾≥6.5 mmol/L,HR=2.33,95%CI 1.80~3.01,P<0.001)和CVD死亡(5.5≤血钾<6.0 mmol/L,HR=1.65,95%CI 1.13~2.43,P=0.001;6.0≤血钾<6.5 mmol/L,HR=1.75,95%CI 1.08~2.82,P=0.023;血钾≥6.5 mmol/L,HR=2.70,95%CI 1.70~4.29,P<0.001)的独立危险因素.结论:MHD患者透析前高血钾发生率为 24.7%,是患者 3 月内全因死亡和CVD死亡的独立危险因素,且血钾水平越高,死亡风险越大.
Hyperkalemia on all-cause and cardiovascular disease mortality within 3 months in maintenance hemodialysis patients
Objective:To investigate the effect of serum potassium concentrations on all-cause mortality and cardiovascular disease(CVD)mortality within 3 months in maintenance hemodialysis(MHD)patients.Methodology:A multicenter retrospective cohort study.The general information and laboratory indicators of patients newly entered MHD in the registration system of Zhejiang province dialysis quality control center from January 1,2010 to December 31,2019 were collected.Serum potassium was selected as the highest value of serum potassium before dialysis within 3 months before the end of follow-up.The patients were divided into 8 groups according to the serum potassium level,and the Kaplan-Meier method was used to compare the survival differences between all-cause mortality and CVD mortality in each group,and the multivariate COX regression model was used to analyze the relationship between serum potassium level and all-cause mortality and CVD mortality.Results:A total of 21 861 patients aged(61.1±15.4)years old were included,including 13 465 males(61.6%),and10 132 patients(46.3%)with cardiovascular diseases.The median follow-up time was 34(19,56)months,4 635 cases(21.2%)all-cause died,including 1 319 cases(6.0%)with cardiovascular disease.759 patients(3.5%)with serum potassium<3.5 mmol/L,9 782 patients(44.7%)with serum potassium≥5.0 mmol/L,and 5 420 patients(24.7%)with serum potassium≥5.5 mmol/L.Kaplan-Meier survival curve showed that the risk of all-cause mortality(Log-rank test,χ2=248.0,P<0.001),and the risk of cardiovascular mortality(Log-rank test,χ2=96.6,P<0.001)were significantly different among eight groups.Multivariate COX regression analysis showed that serum potassium level≥5.5 mmol/L was an independent risk factor for all-cause mortality(5.5≤K<6.0 mmol/L,HR=1.34,95%CI 1.08~1.67,P=0.008;6.0≤K<6.5 mmol/L,HR=1.53,95%CI 1.18~2.00,P=0.001;K≥6.5 mmol/L,HR= 2.33 95%CI 1.80~3.01,P<0.001)and CVD mortality(5.5≤K<6.0 mmol/L,HR= 1.65,95%CI 1.13~2.43,P= 0.001;6.0≤K<6.5 mmol/L,HR= 1.75,95%CI 1.08~2.82,P= 0.023;K≥6.5 mmol/L,HR= 2.70,95%CI 1.70~4.29,P<0.001)within 3 months in MHD patients.Conclusion:Serum potassium≥5.5 mmol/L was an independent risk factor for all-cause mortality and CVD mortality within 3 months in MHD patients,and the higher the serum potassium level,the greater the risk of death.

hemodialysisserum potassiummortalitycardiovascular disease

金灿、陈思瑜、盛凯翔、陈江华、张萍

展开 >

浙江大学医学院附属第一医院肾脏病中心、浙江省肾脏病防治技术研究重点实验室、国家临床重点专科,浙江大学肾脏病研究所、浙江省肾脏与泌尿系统疾病临床医学研究中心(杭州 310003)

浙江大学医学院附属金华医院 金华市中心医院肾内科

血液透析 血钾 死亡率 心血管疾病

浙江省卫计委省部共建项目

2016153789

2024

肾脏病与透析肾移植杂志
金陵医院肾脏病研究所

肾脏病与透析肾移植杂志

CSTPCD
影响因子:1.091
ISSN:1006-298X
年,卷(期):2024.33(1)
  • 23